eIF2A has minimum effect on cell proliferation and global translation.

(A) Validation that eIF2A knockout cells have no eIF2A protein by immunoblotting.

(B) Two independent eIF2A knockout HeLa cell lines have no proliferation defect, assayed by CellTiter Glo. Error bars: standard deviation. Significance by ordinary one-way ANOVA.

(C-D) eIF2A knockout HeLa cells have no detectable change in global translation rates compared to control cells. (C) The translation rate was measured by immunoblotting to detect OPP incorporated by metabolic labeling (left), and normalized to total protein amount assayed by PonceauS (right). Three independent replicates are quantified in panel (D). Error bars: standard deviation. Significance by ordinary one-way ANOVA.

(E-F) Polysome profiles of eIF2AKO cells show little to no difference to profiles from control cells. Lysates from either control or eIF2KO HeLa cells were separated on a sucrose gradient. One representative graph is shown in panel D. The polysome/80S ratio of three independent replicates is shown in panel F. Error bars: standard deviation. Significance by ordinary one-way ANOVA.

Ribosome profiling of eIF2A-KO lines finds little impact of eIF2A on translation.

(A) Ribosome profiling identifies a handful of mRNAs sensitive to eIF2A depletion. Scatter plot of log2(fold change of Translation Efficiency eIF2AKO/ control) versus significance. Significant candidates with log2(fold change) < -1 are shown in red. Significance was estimated with the Wald test performed by the DESeq2 package. p-values are adjusted for multiple comparison.

(B-D) Western blot validation of ribosome profiling results. Among the tested candidates, only CCND3 shows decreased protein levels in one eIF2AKO clone. Representative blot in (B), of triplicates quantified in (C). mRNA levels of the corresponding transcripts are quantified and shown in (D). Significance by Dunnett’s multiple comparison test ANOVA. error bar = st. dev., ns = not significant, * p < 0.05, ** p < 0.01

(E) Luciferase reporters harboring 5’ UTRs of eIF2A-dependent transcripts do not show strong changes in expression upon loss of eIF2A. Reporters carrying the 5’ UTRs of the indicated candidate genes were cloned upstream of Renilla Luciferase (RLuc) and co-transfected with a Firefly Luciferase (FLuc) normalization control. The negative control RLuc reporter and the FLuc normalization control carry the 5’UTR of Lamin B1 (LMNB1). Significance by Dunnett’s multiple comparison test ANOVA. error bar = st. dev., ns = not significant, * p < 0.05, ** p < 0.01, ***<0.001

eIF2A has little or effect on uORF translation.

(A) Synthetic reporters harboring uORFs with different start codons and initiation contexts do not show dependence on eIF2A. The sequence context of the uORF start codons is indicated: either canonical AUG or a near-cognate start codon (GTG, TTG, CTG) was used. Significance by Dunnett’s multiple comparison test ANOVA, error bar = st. dev. ns = not significant.

(B) Validation that HEK293T-H2-Kb eIF2AKO cells have no eIF2A protein by immunoblotting.

(C) Schematic diagram illustrating the setup to simultaneously detect a small peptide produced by a uORF and fluorescent mNeonGreen encoded by the main ORF. The short peptide SIINFEKL is presented on the cell surface by MHC-I and detected using a monoclonal antibody.

(D) eIF2A knockout does not cause a drop in uORF translation. In the graph to the right, the percent of uORF-positive cells relative to all mNeonGreen cells is quantified. Significance by unpaired, two-sided, t-test. ns = not significant.

eIF2A has a minor impact on translation during the integrated stress response.

(A) Loss of eIF2A does not blunt induction of target genes of the integrated stress response. Reporters carrying the 5’ UTRs of the indicated candidate genes were co-transfected with a Firefly Luciferase (FLuc) normalization control reporter into eIF2AKO and control HeLa cells and treated for 16 hours either with DMSO or 1µg/ml tunicamycin (TM). Significance by Dunnett’s multiple comparison test ANOVA. error bar = st. dev., ns = not significant, * p < 0.05, ***<0.001

(B) Ribosome profiling identifies 12 mRNAs that are significantly induced upon tunicamycin treatment (1 ug/ml) in control cells but not eIF2AKO cells. Scatter plot of log2(fold change) of Translation Efficiency TM/DMSO for control cells on the x-axis versus eIF2AKO cells on the y-axis. mRNAs that are statistically significantly induced with log2(fold change)>1 in control cells but not in eIF2AKO cells are shown in yellow and marked by gene name. Significance was estimated with the Wald test performed by DESeq2 package. p-values are adjusted for multiple comparison.

(C) Transfection of luciferase reporters harboring 5’ UTRs of eIF2A-dependent transcripts do not show impaired induction in eIF2AKO cells upon tunicamycin treatment. 5’ UTRs of eIF2A-dependent transcripts from panel B were cloned upstream of Renilla luciferase and co-transfected with a Firefly Luciferase (FLuc) normalization control reporter into control or EIF2AKO HeLa cells with subsequent treatment for 16 hours either with DMSO or 1ug/ml tunicamycin (TM). Significance by Dunnett’s multiple comparison test ANOVA. error bar = st. dev., ns = not significant, * p < 0.05.

Loss of eIF2A does not perturb cell proliferation and global translation.

(A) Genotyping of eIF2AKO cell lines. Two eIF2A knockout lines were generated by targeting two separate coding exons. Shown is the resulting mutation at the DNA level, and a schematic of the predicted protein product.

(B) mRNA levels of eIF2A, quantified by qRT-PCR, are reduced in the eIF2AKO lines. Error bars: standard deviation. Significance by ANOVA with Dunnett’s multiple comparison test.

(C-D) Subcellular localization of eIF2A, detected by immunoblotting cytosolic and nuclear fractions, does not change upon treatment with tunicamycin (TM). Cells were treated with DMSO or Tunicamycin (1 µg/µl) for 2 hours. (C). Representative immunoblot (C) of three independent replicates quantified in (D). Error bars: deviation. Significance by multiple unpaired, t-test.

(E) Overexpressed FLAG-eIF2A shows predominantly cytoplasmic localization, assessed by immunofluorescent staining with anti-FLAG antibodies. Cells transfected with plasmid expressing eIF2A-FLAG were treated for 1 hour either with DMSO or 100 µM Sodium arsenite (SA).

(F-G) eIF2A levels in HeLa cells are not affected by poly (I:C) (1µg/ml), LPC (1 µg/ml) or tunicamycin (1µg/ml) for 3 hours. Phospho-p38 signal is used as a positive control for the treatment. Representative immunoblot (F) or three independent replicates quantified in (G). Error bars: standard deviation. Significance by ANOVA with Dunnett’s multiple comparison test.

(H-I) Global protein translation levels in HeLa cells do not change upon Flag-eIF2A overexpression, assessed by immunoblot against OPP (left) and normalized to total protein amount assayed by PonceauS (right). Representative blots in (H), of four independent replicates quantified in (I). Error bars: standard deviation. Significance by unpaired, two-sided, t-test. All panels: ns = not significant.

Ribosome profiling of control and eIF2AKO HeLa cells.

(A) Reproducibility between replicates of Ribosome profiling and total-mRNA libraries is shown. Three biological replicates were generated for control and eIF2AKO HeLa cells each. The Pearson’s coefficient (r) is shown for each compared pair.

(B-C) Metagene profiles of footprints aligned to either the start codon (B) or the stop codon (C) of all main Open Reading Frames, for control and eIF2AKO HeLa cells. “Smooth” curves were generated by averaging read counts with the sliding window of 3 nt. The dotted lines indicated standard deviation between three replicates.

Loss of eIF2A does not affect translation of multiple different types of reporters.

(A) Luciferase reporters harboring 5’ UTRs of transcripts predicted to be eIF2A-dependent from ribosome footprinting, do not show significantly reduced translation upon siRNA mediated knockdown of eIF2A. The 5’ UTRs of the indicated genes were cloned upstream of Renilla Luciferase (RLuc) and co-transfected with a Firefly Luciferase (FLuc) normalization control reporter. Negative control RLuc reporter and the FLuc normalization control carry the 5’UTR of lamin B1 (LMNB1). Significance by multiple unpaired t-test, ns = not significant. Error bars represent standard deviation.

(B) Western blot control for efficiency of siRNA-mediated knockdown of eIF2A.

(C) Transfection of luciferase reporters designed to place the ribosome directly on top of the initiation AUG do not show reduced translation in eIF2AKO cells compared to controls. A 5’UTR containing the EMCV IRES or a short 5’ UTR of only 12 nt was cloned upstream of Renilla Luciferase (RLuc) and co-transfected with a Firefly Luciferase (FLuc) normalization control. Negative control RLuc reporter and the FLuc normalization control carry the 5’UTR of Lamin B1 (LMNB1). Significance by ANOVA with Dunnett’s multiple comparison test. error bar = st. dev., ns = not significant.

Knockout of eIF2A has no effect on uORF translation.

(A-B) Metagene profiles of footprints relative to either the start codon (A) or stop codon (B) of uORFs transcriptome-wide, for control or eIF2AKO HeLa cells. “Smooth” curves were generated by averaging footprint counts with a sliding window of 3nt. The dotted lines indicated standard deviation between three replicates.

(C) eIF2A has little impact genome wide on translation of mRNAs with uORFs. Comparison of the change in translation efficiency between eIF2AKO and control HeLa cells for three different groups of mRNAs: all transcripts, transcripts with AUG-initiated uORFs, or transcripts with uORFs that start with a near-cognate codon. Significance by ANOVA with Dunnett’s multiple comparison test. ns = not significant, *** p<0.001

(D) Proliferation of eIF2AKO or control HEK293T-H2-Kb cells by CellTiter Glo. Error bars: standard deviation. Significance by unpaired, two-sided, t-test. ns = not significant.

(E) Global cellular translation, assayed via polysome profiles, shows little difference between eIF2AKO and control HEK293T-H2-Kb cells. Lysates from either eIF2AKO or control HEK293T-H2-Kb cells were separated on sucrose gradients. One representative graph is shown in (E). The polysome/80S ratio of three independent replicates is shown in (F). Error bars: standard deviation. Significance by unpaired, two-sided, t-test. ns = not significant.

The Integrated Stress Response suppresses translation equally well in control and eIF2AKO HeLa cells.

(A-B) Polysome profiles of eIF2AKO versus control HeLa cell lines show hardly any differences upon stress caused either with (A) 1 µg/ml tunicamycin (TM) for 16 hours or (B) 100µM sodium arsenite (SA) for 1 hour. Profiles were aligned by the height of the 80S peak.

(C-D) eIF2A knockout cells form stress granules to the same degree as the parental control HeLa cell line. Control or eIF2AKO HeLa cells were treated for 2 hours with 100 µM sodium arsenite and stained for G3BP1. (C) Representative images. (D) The number of stress granules, normalised to the number of nuclei in each field of view is shown. Significance by ANOVA with Dunnett’s multiple comparison test. ns = not significant.

(E) eIF2AKO and control HeLa cells phosphorylate eIF2α to the same degree in response to tunicamycin (1µg/mL for 16 hours). ATF-4 is used as a marker for downstream activation of the integrated stress response.

Ribosome profiling of tunicamycin treated eIF2AKO and control HeLa cells.

(A) Reproducibility between replicates of Ribosome profiling or total-mRNA libraries from eIF2AKO or control HeLa cells treated with tunicamycin. Two biological replicates were generated for each genotype. The Pearson’s coefficient (r) is shown for each comparison.

(B) Ribosome profiling identifies zero transcripts affected by eIF2A knockout in tunicamycin treated condition. Scatter plot of log2(fold change) of Translation Efficiency comparing eIF2AKO to control HeLa cells, both treated with tunicamycin, on the x-axis, versus significance on the y-axis. Significant candidates with log2(fold change) < -1 are shown in red. Significance was estimated with the Wald test performed by DESeq2 package. p-values are adjusted for multiple comparison.

(C-D) Metagene profiles of footprints aligned to either the start codon (C) or the stop codon (D) of all main Open Reading Frames, for control and eIF2AKO HeLa cells, both treated with tunicamycin. “Smooth” curves were generated by averaging read counts with the sliding window of 3 nt. The dotted lines indicate standard deviation between three replicates.

Translation of uORF-bearing transcripts is not affected upon loss of eIF2A in tunicamycin treated cells.

(A-B) Metagene profiles of footprints relative to either the start codon (A) or stop codon (B) of uORFs transcriptome-wide, for control or eIF2AKO HeLa cells, both treated with tunicamycin. “Smooth” curves were generated by averaging footprint counts with a sliding window of 3nt. The dotted lines indicated standard deviation between three replicates.

(C) eIF2A has little impact genome wide on translation of mRNAs with uORFs in cells treated with tunicamycin. Comparison of the change in translation efficiency between eIF2AKO and control HeLa cells, both treated with tunicamycin, for three different groups of mRNAs: all transcripts, transcripts with AUG-initiated uORFs, or transcripts with uORFs that start with a near-cognate codon. Significance by ANOVA with Dunnett’s multiple comparison test. ns = not significant.

(D) Synthetic reporters harboring uORFs with different start codons and initiation contexts do not show dependence on eIF2A also when the integrated stress response is activated, thereby inactivating eIF2α. Either control or eIF2AKO HeLa cells were transfected with the indicated reporters and then treated with 1µg/mL tunicamycin for 16 hours prior to assaying luciferase activity. The sequence context of the uORF start codons is indicated: either canonical AUG or a near-cognate start codon (GTG, TTG, CTG) was used. Significance by Dunnett’s multiple comparison test ANOVA, error bar = st. dev. ns = not significant. * p < 0.05, ** p < 0.01.

Expression of initiation factors reported to possess tRNAiMe binding activities.

(A) Heat map showing the log2 fold change of translation efficiency (eIF2AKO/control cells) of different initiation factors reported to possess binding capacity to tRNAiMet. Changes in DMSO and Tunicamycin treated samples are shown.